How does hyalobarrier gel influence ovulation and pregnancy outcomes in women with scarring around the tubes and ovaries?

ISRCTN ISRCTN18335881
DOI https://doi.org/10.1186/ISRCTN18335881
Secondary identifying numbers 11/H0504/6
Submission date
27/07/2016
Registration date
14/09/2016
Last edited
05/12/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
An adhesion is a type of scar tissue that can make the tissues or organs inside the body stick together. This type of scarring is often caused by undergoing a laproscopy (a type of operation in which the surgeon accesses the inside of the abdomen (tummy) or pelvis through a small cut. If the adhesions are around the fallopian tubes and ovaries, it can reduce fertility, as it can interfere with the monthly release of an egg necessary for conception. The removal of scarring using an anti-scarring gel is potentially useful for stopping scars from reforming after surgery. But it is not known if the gel will influence ovulation (egg production) monthly. The aim of this study is to find out whether using an anti-scarring gel called Hyalobarrier after a laproscopy has an effect on the function of ovaries.

Who can participate?
Women aged between 18 and 28 who are undergoing a laproscopy for the treatment of a condition relating to the female reproductive system, who have possible

What does the study involve?
Participants are randomly allocated to one of two groups. Both groups undergo a laproscopy according to standard procedure, but those in the first group have 10ml hyalobarrier applied around the operative site. Participants have levels of reproductive hormones measured at the start of the study and then again after three and six months, as well as undergoing ultrasound scanning at the same times to monitor their egg production.

What are the possible benefits and risks of participating?
There are no direct benefits or risks involved for participants taking part in this study.

Where is the study run from?
Princess Anne Hospital, Southampton (UK)

When is the study starting and how long is it expected to run for?
November 2011 to November 2014

Who is funding the study?
Nordic Pharma Ltd. (UK)

Who is the main contact?
Professor Ying Cheong
y.cheong@soton.ac.uk

Contact information

Prof Ying Cheong
Scientific

Human Development and Health
University of Southampton Faculty of Medicine
Level F
Princess Anne Hospital
Coxford Road
Southampton
SO16 5YA
United Kingdom

ORCiD logoORCID ID 0000-0001-7687-4597
Phone +44 (0)2380 216033
Email y.cheong@soton.ac.uk

Study information

Study designRandomised controlled pilot study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleRandomsied controlled trial of hyalobarrier versus no hyalobarrier on the ovulatory status of women with peri-ovarian adhesions: a pilot study
Study objectivesThe aim of this study is to compare the ovarian function of women who have peri-ovarian adhesiolysis with and without Hyalobarrier as an anti-adhesion barrier.
Ethics approval(s)South Central Hampshire A Ethics Committee, 13/01/2011, ref: 11/H0504/6
Health condition(s) or problem(s) studiedAdnexal adhesions
InterventionParticipants are randomised to one of two groups using a computer generated random numbers table and opaque envelopes.

Intervention group: Participants receive hyalobarrier get at laparoscopy. This involves having 10ml hyalobarrier applied around the operative site was applied as per manufacturer’s instruction.
Control group: Participants receive no hyalobarrier gel at laparoscopy.

Follow up for all participants involves hormonal profiling (Day 2/3 FSH and LH, and Day 21 progesterone) plus follicular tracking using ultrasonography at month 3 and month 6 post operatively.
Intervention typeProcedure/Surgery
Primary outcome measureOvulatory status is measured using serum hormonal status (Day 2 FSH, LH and Day 21 progesterone) prior to the surgery and at 3 and 6 months after the surgery. Post-operatively, the participant will also undergo a follicular tracking cycle at 3 and 6 months.
Secondary outcome measuresClinical pregnancy is measured by the presence of a fetal heart at 5-6 weeks gestation.
Overall study start date01/11/2011
Completion date01/11/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit38 Years
SexFemale
Target number of participants30
Key inclusion criteria1. Aged between 18-38
2. Women were undergoing operative laparoscopy for gynaecological pathology, with possible peri-ovarian adhesions
Key exclusion criteria1. Presence of malignancies or a history of malignancies
2. Women on medications that affected ovulation
3. Women with known conditions that resulted in anovulation (PCOS, Pituitary causes)
Date of first enrolment01/02/2012
Date of final enrolment01/02/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Princess Anne Hospital
Coxford Road
Southampton
So16 5YA
United Kingdom

Sponsor information

Princess Anne Hospital Southampton
Hospital/treatment centre

Coxford Road
SO16 5YA
SO16 5YA
England
United Kingdom

ROR logo "ROR" https://ror.org/02yjksy18

Funders

Funder type

Industry

Nordic Pharma Ltd.

No information available

Results and Publications

Intention to publish date01/11/2017
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal within 3 years from the trial completion date.
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2017 Yes No

Editorial Notes

05/12/2016: Publication reference added.